NCT01710826View on ClinicalTrials.gov

A Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of Genz-682452 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

February 28, 2013

Study Completion Date

February 28, 2013

Conditions
Healthy
Interventions
BIOLOGICAL

Genz-682452

Capsules for oral administration.

BIOLOGICAL

Placebo

Placebo capsules matching the Genz-682452 capsules.

Trial Locations (1)

Unknown

Austin

All Listed Sponsors
lead

Genzyme, a Sanofi Company

INDUSTRY

NCT01710826 - A Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of Genz-682452 in Healthy Volunteers | Biotech Hunter | Biotech Hunter